back to About us

Explore About us

Explore About us

The world in 1989 was rapidly changing and nowhere more so than in Portugal. Our country was awakening to the need to break with traditional economic models heavily reliant on primary resources, inexpensive products and cheap labour.

A couple of Portuguese scientists nurtured the audacious idea of bringing public institutions together with private companies to work towards a common goal: harvesting the knowledge created by the former and transferring it to the economy and to society in order to create wealth and quality of life. These visionaries created the Instituto de Biologia Experimental e Tecnológica – iBET.

iBET is a private not for profit research intensive SME in the area of Biotechnology and Life Sciences. Set up in 1989, iBET bridges university and industry research by establishing partnerships particularly in the areas related to Biopharma and Food & Nutraceuticals, while also creating and organizing autonomous knowledge and expertise. Thirty years later, iBET is now the largest private Portuguese non-profit institution devoted to Biotechnology Research.

iBET is a certified service provider offering solutions for Biopharmaceuticals & Advanced Therapy Medicinal Products (ATMPs), and for Foods, Nutraceuticals & Bioactive Ingredients.

iBET’s infrastructure comprises cutting edge laboratories, a Good Manufacturing Practices (GMP) certified Analytical Services Unit and a Pilot Plant Unit providing protein and virus production, bioprocess development technologies and production process scale up services for biologics. iBET also has access to the GMP manufacturer GenIbet (iBET’s spin-off sold to Recipharm in January 2022) which together allows iBET to present solutions for the development of Biopharmaceuticals, from R&D all the way up to Phase I/II clinical trials.

iBET hosts 4 satellite laboratories (Novartis, Bayer, Merck and Sanofi) and has a broad network of collaborations, ranging from national and international companies, research institutes, foundations and public institutions. It also serves as an incubation platform for start-up/spin-off companies.

iBET is also the coordinator of the “iNOVA4Health-Advancing Precision Medicine” Research Unit – funded by Fundação para a Ciência e Tecnologia (FCT)-, a translational medicine program organizing the efforts of biomedical researchers involved in biological understanding of disease, lead compounds and biopharmaceuticals pre-discovery; technological scientists involved in preclinical development; and clinicians involved in early clinical and “first-in-man” clinical trials, from institutions within NOVA University of Lisbon.

Along with ITQB NOVA and the Instituto Nacional de Investigação Agrária e Veterinária (INIAV), iBET belongs to the Agrotech Oeiras Campus. This consortium, the largest in the country of its kind, aims to promote research and experimental development of agriculture and forestry, animal health and plant sanity and technology and innovation for bioeconomy. It also supports advanced and specialized training of researchers and technicians, namely in agro-biotechnology, agro-industry and forestry.

Importantly, iBET was one of the first research institutions to be awarded the status of Laboratório Associado (LA) by the Portuguese Ministry of Science and Technology, in 2001. This status, given to institutions rated as excellent in research after international peer review evaluation, allowed iBET to establish a partnership with IGC and ITQB NOVA, and later CEDOC to maximize its research in Biologically Active Molecules, Molecular Medicine, Developmental Biology, Biological Risk and Plant Biotechnology.

iBET has a privileged location only 15 Km west of Lisbon on the coast with easy and close access to main transportation routes to Lisbon (by public transportation and private car).

Milestones

Filter your search by

Definições de Cookies

O iBET pode utilizar cookies para memorizar os seus dados de início de sessão, recolher estatísticas para otimizar a funcionalidade do site e para realizar ações de marketing com base nos seus interesses.

Permitem personalizar as ofertas comerciais que lhe são apresentadas, direcionando-as para os seus interesses. Podem ser cookies próprios ou de terceiros. Alertamos que, mesmo não aceitando estes cookies, irá receber ofertas comerciais, mas sem corresponderem às suas preferências.
Oferecem uma experiência mais personalizada e completa, permitem guardar preferências, mostrar-lhe conteúdos relevantes para o seu gosto e enviar-lhe os alertas que tenha solicitado.
Permitem-lhe estar em contacto com a sua rede social, partilhar conteúdos, enviar e divulgar comentários.